Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1968-10-2
|
pubmed:language |
pol
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0033-2674
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
455-8
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:4875480-Adolescent,
pubmed-meshheading:4875480-Adult,
pubmed-meshheading:4875480-Aged,
pubmed-meshheading:4875480-Clinical Trials as Topic,
pubmed-meshheading:4875480-Humans,
pubmed-meshheading:4875480-Middle Aged,
pubmed-meshheading:4875480-Neurotic Disorders,
pubmed-meshheading:4875480-Tranquilizing Agents
|
pubmed:articleTitle |
[Clinical evaluation of mesoridazine(NC 123) Sandoz].
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|